@bradloncar $Cncr https://t.co/whiFxrDSaO $Zyme, etc. but no $Gmab for #DuoBody &amp; $JNJ!? Also perfect time to reconsider adding $Afmd... there’s no denying bi-specific Abs are the future of #IO... market window for CAR-T/CAR-NK therapies will obviously close fast now. https://t.co/A2eADZ2qOv